Investigating the Link between Influenza Virus and Bacterial Infections

Researchers at St. Jude Children’s Research Hospital utilize superresolution technology  Single S. pneumonia bacterium (green) with multiple influenza virions (red) all over the surface On a recent cover of Nature Microbiology, you will find superresolution microscopy images captured by the laboratory of Dr. Jason Rosch at St. Jude Children’s Research Hospital, Memphis, USA. These images,... Read more

Xylem to host its 2020 Investor and Analyst Day

RYE BROOK, N.Y.–(BUSINESS WIRE)–Feb. 4, 2020– Xylem Inc. (NYSE: XYL), a leading global water technology company focused on addressing the world’s most challenging water issues, will host its 2020 Investor and Analyst Day on Tuesday, March 31, in Atlanta, GA, at the Company’s Data Analytics & Software Center of Excellence. Xylem President and Chief Executive... Read more

Roche reports very strong results in 2019

Basel, 30 January 2020 Group sales increase 9%1 at constant exchange rates and 8% in Swiss francs, driven by new products, more than compensating for impact of competition from biosimilars Pharmaceuticals Division sales up 11%, resulting from high demand for recently launched medicines, led by Ocrevus, Hemlibra, Tecentriq and Perjeta Diagnostics Division sales grow by... Read more

Material Characterization in Additive Manufacturing

From powder to reliable parts: a webinar highlighting light microscopy solutions Additive manufacturing is one of the top trends in academic research and industry. Its unique benefits include: New design possibilities – providing engineers with the freedom to innovate as well as light weight construction New materials – including high temperature resistance and improved mechanical... Read more

JEOL Ltd. Acquires IDES

Acquisition of INTEGRATED DYNAMIC ELECTRON SOLUTIONS, INC. 2020/01/17 JEOL Ltd. (headquartered in Akishima, Tokyo; JEOL hereafter) acquired all shares of INTEGRATED DYNAMIC ELECTRON SOLUTIONS, INC. (headquartered in California, USA; IDES hereafter), an entrepreneurial venture specialized in technologies related to transmission electron microscopy (TEM hereafter), and made IDES its wholly-owned subsidiary. Background and Objective JEOL is... Read more

Gram Staining in Medical Microbiology

Learn the protocol and understand the results of gram staining in this application note Gram staining is a well established method of staining bacteria. It is an important part of the diagnosis of infectious diseases, since gram-positive and gram-negative bacteria are often treated using different antibiotics. Click to download this application note on gram staining... Read more

Luminex Corporation Announces 2019 Highlights and 2020 Guidance; Company to Present at 38th Annual J.P. Morgan Healthcare Conference

AUSTIN, Texas, Jan. 12, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced 2019 highlights and 2020 guidance. All amounts in this release are in conformity with U.S. generally accepted accounting principles (“GAAP”).   Preliminary results, contained herein, are based on management’s initial analysis of operations for the quarter and year ended December 31, 2019... Read more

QIAGEN celebrates surpassing 2,500 cumulative placements of QIAsymphony 

Hilden, Germany, and Germantown, Maryland, January 9, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,500th placement of QIAsymphony, the leading Sample to Insight workflow automation solution for molecular laboratories worldwide, in Tübingen, Germany. Cenata GmbH is a medically led genetic diagnostic laboratory offering prenatal testing, and repeat customer of... Read more

QIAGEN concludes strategic alternatives review; decides to focus on stand-alone business strategy to drive future value creation

Venlo, The Netherlands, December 24, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) (“QIAGEN” or the “Company”) today announced that it has concluded the previously announced review of potential strategic alternatives, and has determined the execution of its current stand-alone business plan represents the best opportunity to drive future value creation. The Supervisory... Read more

Takara Bio Report2019

About Us Message from the president Corporate Data and Subsidiaries Corporate Executives Directions to Takara Bio Quality Assurance Policy Consolidated Subsidiaries Business Outline Bioindustry Gene Therapy News Release Investor Relstions Management Policy Financial Data IR Library Stock Information IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide Products Site About Us Business Outline... Read more